Skip to content

EBIT at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
$44.16M+7.6%
Altimmune logo
AltimmuneALT
-$24.24M-11.1%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$11.89M-7.0%
Wave Life Sciences logo
Wave Life SciencesWVE
-$31.3M+37.2%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
-$789.47M-5,100%
Boston Scientific logo
Boston ScientificBSX

Other financials

Income statement

See full
Revenue$25.0M+26.3%
Gross profit$21.3M+25.5%
Operating income-$1.6M-355%
Net income-$1.1M-200%
EPS (diluted)-$0.03-200%

Balance sheet

See full
Cash & equivalents$41.3M+223%
Total debt$907.0K-10.7%
Total equity$112.7M+40.5%
Total assets$124.8M+43.0%

Cash flow

See full
Operating cash flow$857.0K-61.1%
CapEx$570.0K+307%
Free cash flow$287.0K-86.1%

Valuation

See full
Market cap$425.31M-11.8%
Enterprise value$384.91M-18.2%
P/E120.6×
P/S4.7×-4.3×

Profitability

See full
Gross margin86%+1.1pp
Operating margin-118.1%-56.8pp
Net margin1.5%+0.8pp
FCF margin21.2%+15.2pp

Returns & leverage

See full
Return on equity1.9%+1.0pp
Debt / equity0.0×
Current ratio11.2×-4.7×

Where this comes from

Calculated from Delcath Systems’s reported figures.

The official record: Delcath Systems’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Delcath Systems's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Delcath Systems's EBIT?
Delcath Systems (DCTH) reported EBIT of -$1.64M in Q1 2026.
How has Delcath Systems's EBIT changed year-over-year?
Delcath Systems's EBIT decreased by 355.0% year-over-year, from $642K to -$1.64M.
What is the long-term trend for Delcath Systems's EBIT?
Over 3 years (2021 to 2024), Delcath Systems's EBIT has grown at a -8.9% compound annual growth rate (CAGR), from -$24.53M to -$18.55M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.